|
US2019040450A1
|
|
Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasias
|
|
CA2910311A1
|
|
Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same
|
|
US2014127241A1
|
|
Antibody/drug conjugates and methods of use
|
|
WO2012050892A2
|
|
Methods for stimulating, increasing or enhancing killing of a cell that expresses luteinizing hormone releasing hormone (lhrh) receptors
|
|
WO2011137245A2
|
|
Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
|
|
US2011124564A1
|
|
Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same
|
|
KR20160106191A
|
|
Lytic domain fusion constructs and methods of making and using same
|
